BioCardia Inc (NAS:BCDA)
$ 2.43 0.05 (2.1%) Market Cap: 8.51 Mil Enterprise Value: 8.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Q4 2023 BioCardia Inc Earnings Call Transcript

Mar 27, 2024 / 08:30PM GMT
Release Date Price: $6.29 (-0.21%)
Operator

Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the BioCardia 2023 Year End Financial Results and Business Update Conference Call. (Operator Instructions) Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after one hour after the end of the call.

I would now like to turn the call over to Miranda Peto of BioCardia Investor Relations. Please go ahead, Miranda.

Miranda Peto Benvenuti
BioCardia Inc - IR

Thank you, Rocco. Good afternoon, and thank you for participating in today's conference call. Joining me from BioCardia leadership team are Peter Altman, PhD, President and Chief Executive Officer; and David McClung, the Company's Chief Financial Officer.

During this call, management will be making forward-looking statements, including statements that address BioCardia's expectations for future performance and operational results.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot